Assay Details
Target Gene Details
Entrez Gene ID: | 81620 |
Gene Name: | chromatin licensing and DNA replication factor 1 |
Gene Aliases: |
DUP, RIS2 |
Location: |
Chr.16:88803778-88809258 on Build GRCh38 |
Assay Gene Location: | Overlaps Intron 7 - Exon 8 |
| Gene Symbol | Transcript Accession | Exon Location | Assay Transcript Location | Protein ID |
|---|---|---|---|---|
| CDT1 | NM_030928.3 | NP_112190.2 | ||
| AB053172.1 | BAB61878.1 | |||
| AF070552.1 | ||||
| AF321125.1 | AAG45181.1 | |||
| BC000137.2 | AAH00137.2 | |||
| BC008676.1 | AAH08676.1 | |||
| BC008860.2 | AAH08860.2 | |||
| BC009410.1 | AAH09410.1 | |||
| BC014202.2 | AAH14202.2 | |||
| BC021126.1 | ||||
| BC049205.1 | AAH49205.1 |
Target Copy Number Variation Details
DGV Version: |
Release date: 2016-05-15, GRCh GRCh38 |
| Target Variation |
Location | CNV Subtype |
Genes |
|---|---|---|---|
| nsv1063024 | Chr.16:88707330 - 89238482 on Build GRCh38 | Gain |
|
| nsv457617 | Chr.16:88801844 - 88829729 on Build GRCh38 | Gain |
|
| dgv3064n100 | Chr.16:88683753 - 88846491 on Build GRCh38 | Gain |
|
| nsv573674 | Chr.16:88738775 - 89325907 on Build GRCh38 | Gain |
|
| nsv952071 | Chr.16:88790893 - 89019992 on Build GRCh38 | Deletion |
|
| nsv521217 | Chr.16:88805821 - 89174375 on Build GRCh38 | Loss |
|
| nsv482951 | Chr.16:88633593 - 90228345 on Build GRCh38 | Loss |
|
| nsv1063441 | Chr.16:88767066 - 88861882 on Build GRCh38 | Loss |
|
| dgv37n68 | Chr.16:88767460 - 88944903 on Build GRCh38 | Loss |
|
| esv3639555 | Chr.16:88745961 - 88899576 on Build GRCh38 | Gain |
|
| nsv573715 | Chr.16:88804814 - 88808224 on Build GRCh38 | Loss |
|
| nsv1061256 | Chr.16:88711587 - 89013365 on Build GRCh38 | Gain |
|
| nsv573712 | Chr.16:88796728 - 88809084 on Build GRCh38 | Loss |
|
More Information
Additional Information:
For this assay, SNP(s) [rs74035836] are located under a primer or probe sequence. To help evaluate the possible impact of a given SNP on your experiment, please refer to the 1000 Genomes and NCBI dbSNP databases. A higher minor allele frequency in your study population represents a higher risk to assay performance.
Set Membership: |
|

Genomic Map